THE COMPANY IS ESTABLISHED
Exclusive partnership with Cytyc Corporation and introduction in Greece of the innovative ThinPrep Pap Test.
Beginning of the partnership with the firms Biogyn, Italy and Rovers Medical Devices, Netherlands which are active in gynaecology.
Beginning of the exclusive partnership with Hospira Inc.USA and CIS bio, France
Aenorasis becomes partner of Genomica, Spain in the sector of molecular analysis.
Hologic, USA buys OFF Cytyc Corporation. Aenorasis extends its partnership.
The company moves to a new building.
Successful introduction of the first biosimilar agent in the Greek market.
A new, supermodern storage, distribution and technical support center is built in Koropi.
Aenorasis portfolio on Supportive Treatment is reinforced.
The first biosimilar monoclone antibody approved in EU is introduced in Greece
Hospira Inc. is bought off by Pfizer Inc. Aenorasis extends its successful partnership with Pfizer.